02036nam a2200457 i 4500001001300000003000600013005001700019007001400036008004100050040003000091042000800121043001200129074001600141086002000157110007300177245017500250264007100425300002300496336000800519337001600527338001900543490007700562500002400639500002100663500003600684500002500720504004100745533010600786776014900892776015001041810005801191050002101249610004101270650004601311650003901357650005501396650002901451650003201480650003201512655003401544on1062531130OCoLC20181218152708.0he bmb024bbca181113s2018    dcu     bb   f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---  a1008-D (MF)0 aY 1.1/8:115-7241 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce,10aOverdose Prevention and Patient Safety Act :breport together with dissenting views (to accompany H.R. 5795) (including cost estimate of the Congressional Budget Office). 1a[Washington, D.C.] :b[U.S. Government Publishing Office],c[2018]  a43 pages ;c24 cm.  btxt  bh2rdamedia  bhe2rdacarrier1 aReport / 115th Congress, 2d session, House of Representatives ;v115-724  aTitle from caption.  a"June 12, 2018."  aShipping list no.: 2018-0192-M.  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e1 microfiche : negative.08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce.tOverdose Prevention and Patient Safety Actw(OCoLC)104193560808iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce.tOverdose Prevention and Patient Safety Actw(OCoLC)10419345991 aUnited States.bCongress.bHouse.tReport ;v115-724. 4aKF32b.E55 2018u10aUnited States.tSocial Security Act. 0aPatientszUnited StatesxSafety measures. 0aDrugsxPrescribingzUnited States. 0aOpioid abusexOverdosezUnited StatesxPrevention. 0aChronic painxTreatment. 0aMedicare fraudxPrevention. 0aMedicaid fraudxPrevention. 7aLegislative materials.2lcgft